Molecular Imaging

IMV: PET procedure volumes continue strong growth trend

By Davin Korstjens

Overall PET procedure volumes increased by 12.2% in 2024, according to the IMV 2025 PET Market Summary Report.

April 10, 2025

Having a father with Alzheimer's could mean higher risk of the disease

By Kate Madden Yee

Having a father with Alzheimer's may be tied to a greater spread of the tau protein in the brain, researchers have reported.

April 9, 2025

PET reveals brain’s responses to music

PET has provided the first neuroimaging evidence that music affects the brain’s opioid receptor system.

April 7, 2025

2025 04 07 Pet Music Thumbnail

China limits exports of rare earth elements, targets CT x-ray tubes

By Erik L. Ridley

China's Ministry of Commerce has announced export controls for several rare earth elements and launched investigations of imported CT x-ray tubes.

April 4, 2025

SPECT/CT measure validated for diagnosing ATTR

A research team in Finland has validated the accuracy of a SPECT/CT measure for diagnosing transthyretin amyloidosis.

April 4, 2025

CAC score of 0 indicate low heart event risk, even in older people

By Kate Madden Yee

PET/CT imaging indicates that a coronary artery calcium (CAC) score of 0 is an accurate indicator of low coronary heart event risk even as a person ages, investigators have reported.

March 29, 2025

PET/CT visualizes extremely rare brain inflammation

An F-18 FDG-PET/CT scan proved crucial in identifying an ultrarare case of brain inflammation in a patient due to the flu.

March 27, 2025

Brain MRI and F-18 FDG brain and whole-body PET/CT images. (A) No obvious abnormalities were found in axial and sagittal slices from T2-weighted MR images. (B) Whole cerebellar cortex had diffuse F-18 FDG hypermetabolism in PET/CT brain images, with SUVmax of 25.91. (C and D) Whole-body F-18 FDG-PET/CT showing distended bladder. TLG = total lesion glycolysis; MTV = metabolic tumor volume. Image and caption courtesy of the Journal of Nuclear Medicine.

Targeted alpha therapy’s ‘elite 8’ radionuclides

A select group of eight radionuclides holds hopes for an emerging cancer treatment in nuclear medicine called targeted alpha therapy (TAT).

March 26, 2025

New method proposed for diagnosing Alzheimer’s

Researchers in Germany have proposed a new approach derived from brain PET imaging for diagnosing and staging Alzheimer’s disease.

March 25, 2025

2025 03 25 Fill States Thumbnail

Whole-body PET visualizes COVID-19 infection

Researchers in France have developed a PET imaging approach for longitudinal tracking of the virus that causes COVID-19.

March 24, 2025

2025 03 24 Covid Brain Thumbnail

PSMA PET/CT identifies 'atypical' metastases in prostate cancer patients

PET/CT scans with an experimental PSMA imaging agent can identify supraclavicular nodal metastasis in newly diagnosed prostate cancer patients.

March 21, 2025

F-18 PSMA-1007 PET/CT of a 70 year old with newly diagnosed prostate cancer: PSA 770 ng/ml; Gleason 5 + 5; International Society of Urological Pathology grade 5. The maximum intensity projection images, CT, and fused images show PSMA ligand-avid prostate primary with pelvic, retroperitoneal, and mediastinal nodal spread. Additionally, he had left supraclavicular nodal metastasis (arrows). Image and caption available for republishing under Creative Commons license (CC BY 4.0 DEED, Attribution 4.0 International) and courtesy of EJNMMI Reports.

IAEA touts radionuclide development activities

The IAEA has highlighted its worldwide activities to meet increasing demands for alpha-emitting radionuclides for use in Targeted Alpha Therapy.

March 18, 2025

Page 1 of 602